Wednesday, 4 April 2012

Food And Drug Administration-Restless Leg Syndrome-Parkinson's Disease-Healthday News

Drug Patch Approved for Advanced Parkinson's and Restless Leg Syndrome

TUESDAY, April 3 (Healthday News) -- The Neupro (rotigotine) transdermal system has been approved by the U.S. Food And Drug Administration to treat advanced Parkinson's disease and moderate-to-severe restless leg syndrome, the Belgian drug maker UCB said Tuesday in a news release. read more..

No comments:

Post a Comment